Project 3: Responding to Changing Serological and Viral Information around COVID-19 (RESPOND)

项目 3：应对围绕 COVID-19 不断变化的血清学和病毒信息（RESPOND）

• 批准号: 10222412
• 负责人: Ann Scheck McAlearney
• 金额: $ 48.77万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-18 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10222412
• 关键词: Address; Affect; Basic Science; Behavioral; Bioethics Consultants; COVID-19; COVID-19 pandemic; Caregivers; Clinical; Collaborations; Communication; Communication Tools; Decision Making; Development; Diabetes Mellitus; Disease; Effectiveness; Ensure; Equipment; Exposure to; Face; Family; Fright; General Population; Government; Health; Health Communication; Health Personnel; Health Services; Health behavior change; Heart Diseases; Household; Immune system; Immunity; Individual; Infection; Internet; Interview; Knowledge; Lung diseases; Malignant Neoplasms; Measures; Methods; Mission; Modality; Organizational Change; Outcome; Patients; Perception; Population; Provider; Public Health; Research; Research Methodology; Resolution; Risk; Role; Science; Serologic tests; Serological; Site; Source; Stigmatization; Surveys; Test Result; Testing; Time; Translating; Update; Vaccination; Vaccines; Viral; Virus; Work; cancer therapy; coronavirus disease; cost; disease transmission; empowered; experience; first responder; follow-up; high risk; implementation science; improved; improved outcome; infection risk; insight; news; pandemic disease; population health; response; social media; tool; transmission process; uptake; web site

Project Summary Responding to the COVID-19 pandemic requires research to understand how the virus is transmitted, what types of protection are most effective, how immunity is acquired and persists, and how to best encourage people to make use of available testing and vaccines. As our understanding of serologic and viral testing opportunities and implications of test results improves, so too does our ability to provide guidance to individuals at higher risk from exposure, such as first responders and their household contacts, as well as the general public. Communication about the risks related to COVID-19, which is reliable and tailored to the appropriate audience, empowers individuals to make the best decisions to protect themselves. Further, when a vaccine becomes available, a thorough understanding of the barriers and perceptions related to vaccination will be critical for promoting and facilitating uptake. Translating new basic science discoveries quickly and to the appropriate audiences will thus ensure the effectiveness of initiatives that can address the spread of COVID-19. To that end, Project 3, “Responding to Changing Serological and Viral Information around COVID-19 (RESPOND),” seeks to leverage information and discoveries from Projects 1 and 2, as well as from collaborations with other SeroNet Centers and Components, to develop actionable communication tools for organizations and individuals to empower them to utilize the most up-to-date information to guide their decisions. Using a mixed methods approach, including qualitative interviews and surveys in Year 1, we will first develop a baseline understanding of the communication mechanisms used by stakeholder organizations such as government and administrative health agencies, healthcare provider organizations, and employers of individuals at higher risk of exposure and disease transmission. We will also assess baseline understanding of COVID-19 risks and testing options by individuals at higher risk, including first responders and their household contacts, as well as patients undergoing cancer treatment. In Years 2-5, we will continue our mixed methods approach through follow-up interviews and surveys incorporating new information learned Projects 1 and 2, and from SeroNet collaborators. Throughout the study we will disseminate our findings through a project website presenting communication best practices and providing tools we develop for specific stakeholder audiences, as well as the general public.

项目摘要 回应COVID-19的大流行需要研究才能了解该病毒的传播方式，哪些类型 保护是最有效的，如何获得免疫学和持续的，以及如何最好地鼓励人们 利用可用的测试和疫苗。作为我们对血清学和病毒测试机会的理解以及 测试结果的含义也有所改善，我们的能力也能为来自较高风险的个人提供指导 暴露于急救人员及其家庭联系以及公众。沟通 关于与Covid-19相关的风险，这是可靠的，对适当的受众量身定制的风险， 个人做出最好的决定来保护自己。此外，当疫苗可用时， 对与疫苗接种相关的障碍和看法的彻底理解对于促进和 促进吸收。因此，将新的基础科学发现转化为新的基础科学发现，并将其转化为适当的受众 确保可以解决COVID-19的倡议的有效性。 为此，项目3，“回应Covid-19的血清学和病毒信息的变化 （响应），”试图利用项目1和2的信息以及 与其他Seronet中心和组件的合作，以开发可行的通信工具 组织和个人有权利用最新信息来指导他们的决策。 使用混合方法方法，包括第一年的定性访谈和调查，我们将首先开发一个 对利益相关者组织使用的沟通机制的基线理解，例如 政府和行政卫生机构，医疗保健提供者以及个人的雇主 暴露和疾病传播的风险更高。我们还将评估对Covid-19的基线理解 风险和测试选项的风险和测试选择较高，包括急救人员及其家庭联系， 以及接受癌症治疗的患者。在2 - 5年中，我们将继续我们的混合方法方法 通过后续访谈和调查进口新信息1和2的新信息，并从 Seronet合作者。通过研究，我们将通过项目网站传播我们的发现 介绍沟通最佳实践，并为我们为特定利益相关受众开发的工具，作为 以及公众。